Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06413212
What this trial is testing

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Who this might be right for
Lung CancerBreast CancerGastric Cancer+1 more
Liu Huang 55
Large-scale testing (Phase 3)Looking for participantsNCT06743126
What this trial is testing

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

Who this might be right for
Melanoma, Cutaneous Malignant
Immatics US, Inc. 360
Early research (Phase 1)Active Not RecruitingNCT04387084
What this trial is testing

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

Who this might be right for
Advanced Malignant Skin NeoplasmMetastatic Malignant Skin Neoplasm
University of Southern California 10
Early research (Phase 1)Ended earlyNCT01557114
What this trial is testing

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 19
Testing effectiveness (Phase 2)Study completedNCT02816021
What this trial is testing

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02223884
What this trial is testing

Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Who this might be right for
Malignant Melanoma
Yonsei University 30
Not applicableUnknownNCT02784366
What this trial is testing

GI Complications in Cancer Immunotherapy Patients

Who this might be right for
Malignant Melanoma
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00849875
What this trial is testing

Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
GlaxoSmithKline 48
Not applicableLooking for participantsNCT04764357
What this trial is testing

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

Who this might be right for
Alopecia
St. Jude Children's Research Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00232726
What this trial is testing

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Who this might be right for
Malignant MelanomaNeoplasm Metastasis
Clavis Pharma 42
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Testing effectiveness (Phase 2)UnknownNCT03166397
What this trial is testing

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma Stage IV
Sheba Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396
What this trial is testing

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more
Fred Hutchinson Cancer Center 52
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Large-scale testing (Phase 3)Study completedNCT01307397
What this trial is testing

Vemurafenib in Participants With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 3,219
Testing effectiveness (Phase 2)Study completedNCT02113982
What this trial is testing

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Acute Myeloid Leukemia (AML)
Stemline Therapeutics, Inc. 138
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Testing effectiveness (Phase 2)Study completedNCT01884961
What this trial is testing

Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Who this might be right for
Metastatic Renal Cell CancerMalignant Melanoma, Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 46
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT05293496
What this trial is testing

MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCastration-Resistant Prostatic CancerMalignant Melanoma+4 more
MacroGenics 31
Next Page